Abstract
Intercalating agents, some of them in clinical use, were tested for their ability to inhibit the hepatitis B virus specific DNA polymerase reaction. Ethidium bromide was shown to be the strongest inhibitor among the compounds tested. Compounds in clinical use inhibited the DNA polymerase test only at high concentrations. The inhibitory activity of all compounds tested was increased when the MgCl2 content in the reaction mixture was lowered. UV absorption studies presented no evidence that this effect was due to complex formation of magnesium and the individual compounds. The therapeutic significance of these findings is not certain and needs further work.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dane, D.S., Cameron, C.H., Briggs, M.: Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet,1970 I, 695–698
Goodman, L.S., Bilman, A.: The Pharmacologic Basis of Therapeutics. New York: MacMillan 1975
Hess, G., Shih, J.W-K., Kaplan, P.M., Gerin, J.L.: The Demonstration of Subtype (D or Y)-specific Determinants on the Surface of the Presumed Hepatitis B Virus. J. Immunol.119, 1542–1544 (1977)
Hirschman, S.Z., Garfinkel, E.: Inhibition of hepatitis B DNA polymerase by intercalating agents. Nature271, 681–683 (1978)
Hirschman, S.Z., Vernace, S.J., Schaffner, F.: DNA polymerase in preparations containing Australia antigen. Lancet,1971 I, 1099–1103
Hruska, J.F., Clayton, D.H., Rubenstein, J.L.R., Robinson, W.S.: Structure of Hepatitis B Dane Particle DNA Before and After the Dane Particle DNA Polymerase Reaction. J. Virol.21, 666–672 (1977)
Kaplan, P.M., Ford, E.C., Purcell, R.H., Gerin, J.L.: Demonstration of Subpopulations of Dane Particles. J. Virol.17, 885–893 (1976)
Kaplan, P.M., Greenman, R.L., Gerin, J.L., Purcell, R.H., Robinson, W.S.: DNA Polymerase Associated with human Hepatitis B Antigen. J. Virol.12, 995–1005 (1973)
Lutwick, L.I., Robinson, W.S.: DNA Synthesized in the Hepatitis B Dane Particle DNA Polymerase Reaction. J. Virol.21, 96–104 (1977)
Purcell, R.H., Gerin, J.L., Almeida, J.B., Holland, P.V.: Radioimmunoassay for the detection of the core of the Dane particle and antibody to it. Intervirology2, 231–243 (1974)
Robinson, W.S., Clayton, D.A., Greenman, R.L.: DNA of a human hepatitis B virus candidate. J. Virol.14, 384–391 (1974)
Robinson, W.S., Greenman, R.L.: DNA Polymerase in the Core of the Human Hepatitis B Virus Candidate. J. Virol.13, 1231–1236 (1974)
Siede, W.: Die Therapie der chronischen Hepatitis. Therapiewoche25, 4784–4798 (1975)
Summers, J., O'Connell, A., Millman, I.: Genome of hepatitis B virus: Restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Natl. Acad. Sci.72, 4597–4601 (1975)
Williams, D.H., Gleming, I.: Spectroscopic Methods in Organic Chemistry. Maidenhead: McGraw Hill Publishing Company Ltd. 1966
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hess, G., Arnold, W., Möller, B. et al. Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents. Med Microbiol Immunol 168, 25–34 (1980). https://doi.org/10.1007/BF02121649
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02121649